National Taiwan University Hospital: Leukemia trials
The registry lists 10 Leukemia studies with National Taiwan University Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid LeukemiaEnrolling by invitationNCT05983172
- Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free RemissionRecruitingNCT05439889
- Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic LeukemiaRecruitingNCT04616274
- Pharmacokinetics of Venetoclax in Patients With Acute Myeloid LeukemiaRecruitingNCT04613622
- FLT3 Clonal Evolution in Patients With Acute Myeloid LeukemiaCompletedNCT06463639
- Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell MalignanciesStatus unknownNCT03624686
- Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted TherapyStatus unknownNCT03499912
- Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in TaiwanStatus unknownNCT00526084
- Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) ImageStatus unknownNCT00172562
- Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"Status unknownNCT00155844